PROCEDURE FOR IMMUNISATION
|
|
- Ophelia Chase
- 6 years ago
- Views:
Transcription
1 Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To promote the safe administration of vaccines 2014 Named Responsible Officer:- Approved by Date Medicines Governance Pharmacist Quality, Patient Experience and Risk Group May 2012 Section:- Medicines Management MMSOP12 Target Audience Healthcare Professionals who advise or administer Immunisations to children or adults UNLESS THIS VERSION HAS BEEN TAKEN DIRECTLY FROM THE TRUST WEB SITE THERE IS NO ASSURANCE THIS IS THE CORRECT VERSION
2 CONTROL RECORD Title Procedure for Immunisation Purpose Support Staff when undertaking the required clinical procedure Author Quality and Governance Service (QGS) Equality Assessment Integrated into procedure Yes No Subject Experts A Nugent and L Knight Document Librarian QGS Groups consulted with :- Medicines Management Group Infection Control Approved 10/04/12 Date formally approved by Quality, Patient Experience and Risk Group 1 st May 2012 Method of distribution Intranet Archived Date Location:- S Drive QGS Access Via QGS VERSION CONTROL RECORD Version Number Author Status Changes / Comments Version 1 A Nugent L Knight N To reflect National and Trust immunisation standards for best practice Status New / Revised / Trust Change 2/13
3 PROCEDURE FOR IMMUNIS ATION INT R ODUCT ION This procedure outlines the principles for safe administration of vaccines. Immunisation programmes are one of the most successful public health measures and it is important that professionals provide a rationale outlining the benefits of vaccinations. In addition to this procedure, staff must also refer to the: Immunisation Against Infectious Disease (Green Book) refer to most current chapters on the web site as chapters are frequently updated UK Guidance on Best Practice in Vaccine Administration data/assets/pdf_file/0010/78562/ pdf TARGET GROUP All nurses and clinical staff trained to immunise or advise on immunisation. T R AINING All clinical staff are required to attend Essential Learning training, which includes anaphylaxis and basic life support every two years as outlined in the Trust Mandatory Training Matrix HEALTH VISITING SERVICE See additional training requirements in the Service Training Matrix, which is monitored via annual appraisal by line managers COMMUNITY NURSING See additional training requirements in the Service Training Matrix, which is monitored via annual appraisal by line managers PRACTICE NURSING Immunisation training for specific staff groups will be specified in the Service Training Matrix, which is monitored via annual appraisal by line managers 3/13
4 UNPLANNED CARE NURSES Unplanned care nurses are authorised under Patient Group Direction to administer a tetanus containing vaccine for tetanus prone wounds. See additional training requirements in the Service Training Matrix, which is monitored via annual appraisal by line managers FLU CHAMPIONS Nominated registered nurses within Wirral Community NHS Trust will assist Occupational Health Department to immunise Wirral Community NHS Trust front line staff during the annual flu campaign. Flu champions will attend an in house yearly update on influenza immunization as identified under Nominated Clinical roles in the relevant Service Training Matrix AUTHORISATION AND PAT IE NT G R OUP DIR E C T IONS (PGDS ) It is important that nurses are legally covered to administer vaccines, which are Prescription Only Medicines (POMs). There are two ways in which nurses can be legally covered to administer vaccines: 1. A nurse may administer a vaccine if he/she has a written instruction for the specific vaccine which includes the patient s name and route of administration, this is known as a Patient Specific Direction (PSD) and must be signed and dated by a qualified and registered prescriber. 2. A nurse may administer a vaccine to a patient, if there is an authorised Patient Group Direction for the specific vaccine. The nurse must have signed the PGD and agreed to only administer the vaccine in accordance with the PGD. The PGDs are approved by the Trust and all nurses must read and sign them individually. In addition the nurse s line manager must countersign the PGD to acknowledge that the nurse has the required competencies and authorisation to work within the PGD. Heads of Service are required to keep records of all nurses authorised to work under PGDs according to the Trust s Safe Handling and Administration of Medicines Policy and Clinical Protocol for the Development of PGDs Staff must have a copy of the relevant PGD with them, when administering the vaccines. This is essential to be able to check that the patient fulfills the inclusion criteria and is not excluded as outlined in individual PGDs. 4/13
5 RELATED POLICIES Please refer to relevant Trust policies and procedures CONSENT Refer to Trust Consent Policy for further information and guidance. Specifically for children: All parents/ legal guardians sign their intent to participate in the National Immunisation Programme following the birth of their child or on moving into Wirral. All parents/ legal guardians will be given Department of Health information leaflets on the National Childhood Immunisation Programme, the importance of vaccination and management of potential side effects. Verbal consent must be obtained from a person with parental responsibility, or the child being immunised, if they are Fraser Competent at each immunisation visit. If the immuniser is not satisfied that informed and understood consent has been given, the immunisation should be deferred (Refer to Clinical Protocol for Clarification of Parental Responsibility) PROCESSES FOR CHILDHOOD IMMUNISATIONS Scheduled Appointment System for Children All Wirral children will be allocated appointments generated and coordinated through Wirral Information Services for Child Health (WISCH) as per local Trust agreement For Children s Immunisation The following documents are required: Have a copy of the Generated Appointment list - scheduled immunisation list from the Genesis Team Child Health Department. CH12 Form should be completed for unscheduled immunisations given on the day or changes to consent for listed scheduled vaccinations and forward to Genesis Team at Child Health. A copy of the Health Protection Agency (HPA) Vaccination of individuals with Uncertain or Incomplete immunisation status accessed from Access to patient notes (either computerised, Lloyd George notes, or community patient records) 5/13
6 Personal Child Health Records (Red book) are also required to record the vaccination and confirm any previous vaccination where relevant. For children who have come from outside the UK they may have an equivalent record which would also be acceptable. R E STR AINING CHILDR E N AND YOUNG PE OPLE Restraint is, by definition, applied without child s consent. However, safe parental restraint reduces the risk of needle stick injury to the child. Safe restraint means immobilisation by using limited force. It may be a method of helping children, in order to safely manage a painful procedure (RCN, 2010). This method of holding children may be used if necessary during the immunisation procedure with informed and understood parental consent. This predominately applies to the three to four year old children. Health Professionals must not hold the child in a safe position; this must be done by the parent or person with parental responsibility with guidance from staff. Clinical judgment on what advice to give parents will always be on a case by case basis, the child s welfare and safety will always be paramount. PROCEDURE FOR IMMUNIS AT ION EQUIPMENT Vaccine supply including the manufacturer s information leaflet Patient Documentation as listed above Copy of PGD or PSD Point of Use Disposal System (POUDS) tray Cotton wool Micro pore tape or plasters Yellow lidded Sharps container Selection of syringes 1ml or 2ml (single use only) Selection of needles (single use only) Green 21 gauge 38 mm long - use for drawing up of vaccine medication only (single use only) Orange 25 gauge 25 mm long or blue 23 gauge- 25mm long use to administer vaccines (single use only) refer to the Trust procedure for Administration of Medicines via the Intramuscular Route or the Subcutaneous Route for full details 16mm long, only to be used on pre-term or very small infants (single use only) FOR ADULTS AND CHILDREN Activity Verbally confirm the identity of the patient by asking for their full name and date of birth. If the patient is unable to confirm, check identity with family/carer In case of a child, check accompanying adult has Rationale To avoid mistaken identity To comply with Trust consent policy 6/13
7 parental responsibility Introduce yourself as a staff member and any colleagues involved at the contact At all times wear identity badge which includes name status and designation Check if any allergies Provide a safe and suitable environment and have appropriate equipment available Ensure the correct required vaccines are available and cold chain has been maintained Ensure a current Patient Group Direction (PGD) is in place to cover the specific vaccine to be administered or Patient Specific Direction (PSD) is written Staff must have a copy of the PGD with them when administering the vaccine If in a clinical setting, check the computer system to ensure patient has not previously been vaccinated and sufficient time has lapsed since previous immunisation When immunising children also check the Red Book or equivalent for details of previous immunisation Confirm that the patient or where appropriate carer understands what vaccination(s) are to be given and is aware of possible adverse drug reactions, including how to recognise the symptoms of anaphylaxis If administering the vaccine under PGD check that all the conditions of the PGD are fully met If administering the vaccine under a PSD, ensure the PSD gives full details on vaccine, dose, route, site of injection and includes the date prescribed, the prescribers signature and if administering to a child, the child s date of birth Decontaminate hands prior to procedure Risk assess use of Personal Protective To promote mutual respect and put the patient at their ease To reduce risk of adverse event To help reduce any potential errors during administration of vaccines Vaccines to be stored in accordance with manufacturer s guidance and vaccines transported under cold chain conditions at all times Vaccine supplies delivered to practices will be stored immediately on receipt to maintain cold chain To comply with legislation To comply with legislation To ensure patient does not receive inappropriate immunisations To gain informed and valid consent The onset of anaphylaxis can be delayed and it is essential that urgent medical care is sought as soon as possible To ensure the patient fulfils the inclusion criteria and is not excluded from any of the exclusion criteria To ensure the PSD includes sufficient information To reduce the risk of transfer of transient micro-organisms on the healthcare workers hands 7/13
8 Equipment on an individual patient basis Check vaccine is in date before administration. If required reconstitute vaccine according to the manufacturer s instructions ensuring the vaccine is thoroughly dissolved in the diluent before administration. Vaccines should not be drawn up in advance of an immunisation session. Inspect the vaccine ensuring it is clear from particulate matter and is the correct colour according to the manufacturer s information leaflet If the skin is clean, no further cleaning is necessary. Only visibly dirty skin needs to be washed with soap and water. Administer the vaccine in accordance with the PGD or PSD; also refer to the manufacturer s information leaflet and the Trust procedure for administration of medication via the intramuscular and subcutaneous route. Record the following : batch number and expiry date manufacturer specific name of vaccine administered route and site(s) used including clear description of which injection was administered in each site, especially where two injections were administered in the same limb dose administered date immunisation(s) were given name, signature and designation of immuniser The preferred site for intramuscular immunisation is usually the deltoid area of the upper arm or in children under one the anterolateral aspect of the thigh To ensure the vaccine is not date expired To ensure reconstituted vaccine is thoroughly mixed To ensure vaccines are not administered if they are shown to be not fit for purpose There is evidence that disinfecting the skin makes no difference to the incidence of bacterial complications of injections. Batch number and name of manufacturer is essential for tracking of any relevant problems Injection site avoids major nerves and blood vessels. Most vaccines are administered via the intramuscular route as this route is less likely to cause local reactions. Patients with bleeding disorders may have their immunisation via deep subcutaneous route. Refer to individual specific PGDs or summary of product characteristics for more details. If more than one vaccination is given, record To reduce the risk of bleeding To enable identification of vaccine 8/13
9 each site used, preferably in a different limb. If more than one injection is to be given in the same limb, they should be administered at least 2.5cm apart. Document clearly the site at which each injection is given. Dispose of sharps and any other clinical waste in line with Trust Policy If worn, remove and dispose of Personal Protective Equipment in line with Trust policy Decontaminate hands following procedure Discuss possible adverse effects and management of symptoms and record in health records If symptoms persist advise the patient to contact General Practitioner or Health Professional for advice Recipients of the vaccine should be observed for immediate adverse drug reactions, including observation for any signs of anaphylaxis as identified in the Trust s Procedure for Managing an Anaphylactic Emergency. Record information as per PGD instructions in patient s records/vaccination record form available on the Trust intranet site If attending a care home, ensure a record of the administration is also recorded on the Care Home s Medicines Administration Record regarding any localised reaction To reduce risk of inoculation injury and ensure safe management of healthcare waste To prevent cross infection and environmental contamination To reduce the risk of transfer of transient micro-organisms on the healthcare worker s hands To promote self care of minor adverse effects. Prolonged symptoms may need to be reported via the Yellow Card reporting system There is no evidence to support the practice of keeping patients under longer observation in the clinic or home environment To comply with Trust record keeping standards To ensure staff at the care home are aware patient has been immunised. ADDITIONAL INFORMATION WHEN IMMUNISING CHILDREN Complete scheduled immunisation list checking all details are correct:- child s full name date of birth address date of immunisation to be given and immunisations given to date vaccine scheduled is due NHS Number if available To ensure that the right children receive the correct vaccine and to ensure that consent to vaccines due is unchanged Any discrepancy in details of vaccines due detailed on scheduled immunisation list contact Child Health Genesis Team to check records 9/13
10 Check all of above with the patient s records and related documents Confirm child s name, date of birth, parent/guardian contact details and telephone number on each visit for immunisation. Confirm that the parents/guardian understands what immunisations are due. If any of the immunisations are questioned or declined check the immunisation history to date and check the record is correct Complete scheduled immunisation list and return to Genesis Team, Child Health If administering an unscheduled vaccine complete a CH12 Form and return to Genesis Team Child Health To identify any changes needed to update records To gain informed and valid consent To promote the benefits of gaining immunity, whilst not unduly pressuring the parents/guardian. Genesis Team record all immunisations given Record in Personal Child Health Record for under 5year olds ADDITIONAL INFORMATION WHEN IMMUNISING TRUST STAFF Record information as per PGD instructions in vaccination record form available from Occupational Health Ensure staff member has letter to give to General Practitioner To comply with Trust record keeping standards To ensure the General Practitioner is aware staff member has been vaccinated. ANAPHYLAXIS PRECAUTIONS Adrenaline (epinephrine) 1mg in 1ml ampoules must be available at each immunisation session. The expiry date of the adrenaline must be checked prior to immunising. (Refer to Trust Procedure for Managing Anaphylactic Emergency; also note adrenaline must remain in original manufacturer s packaging) PARENTS WHO DECLINE IMMUNIS AT ION If parents decline any of the immunisations due, explore the reasons why and offer further information and advice on risks and benefits of protecting against disease. Whilst, parents/guardians should not be unduly pressured, they need to be given sufficient information to make an informed decision. When two parents do not agree on vaccines to be 10/13
11 given, advice should be sought from the line manager, in some cases legal advice may be required. If parents decline immunisation, the immuniser should completed CH12 form to advise the Genesis Team at Child Health of any change in consent to scheduled immunisations. Record no consent to immunisation in child notes (computerized, Lloyd George notes or Trust records) and Personal Child Health Record. Offer any additional information to ensure the parent/guardian is making an informed choice, direct them to other sources of immunisation information i.e. Department of Health web site: or alternatively refer to the Wirral University Teaching Hospital Trust Immunisation Lead at Child Health Department. Children who fail to attend should be followed up and another appointment offered. Re-call system is managed by the Genesis Team. R E P OR T ING OF VAC C INE INDUCE D ADVE R SE EFFECTS ADVICE FOR IMMUNIS E R S All suspected vaccine-induced adverse effects should be reported via the Yellow Card scheme. When submitting a Yellow Card, the vaccine brand name and batch number should be provided. Provide information on the nature, timing and severity of the suspected adverse reaction. For further guidance refer to Medicines and Healthcare Products Regulatory Agency s website: Yellow Card reports can be submitted electronically Home - Yellow Card Scheme - MHRA Clinical incidents and near misses must be reported via The Trust s Incident Reporting System DEFECTIVE VACCINES AND B AT C H P R OB L E MS This may include errors in packaging, labels or leaflets or other product faults, such as particulate contamination of a vaccine. If you suspect that a vaccine is defective, do not use the product but contact Defective Medicines Report Centre (DMRC) of the MHRA via web site For further information Health Professionals should refer to updated Chapter 8 of The Green Book Vaccine Safety and Adverse Events Following Immunisation for details of what information is required when submitting reports on suspected defective medicinal products Clinical incidents and near misses must be reported via The Trust s Incident Reporting System 11/13
12 SAFEGUARDING ADULTS AND CHILDREN In any situation where staff have concerns that the patient may be a vulnerable adult or a child in need or at risk, they need to follow the Trust s Safeguarding Policies and discuss with their line manager and document any outcomes. Advice can be sought from the Safeguarding Team. INCIDENT REPORTING Clinical incidents and near misses must be reported via The Trust s Incident Reporting System. REFERRALS Any referrals to health professionals, therapists or other specialist services must be followed up and all professional advice or guidance documented in the patient s health records. WHERE TO GET ADVICE FROM (this list is not exhaustive) Consultant Community Paediatrician (Wirral University Teaching Hospital) Line Manager Genesis Team, Child Health General Practitioner Medicines Governance Pharmacist For medicines advice contact the North West Medicines Information Centre this is an NHS funded resource for all doctors, nurses and allied health professionals pm Mon Friday EQUALITY ASSESSMENT During the development of this procedure the Trust has considered the clinical needs of each protected characteristic (age, disability, gender, gender reassignment, pregnancy and maternity, race, religion or belief, sexual orientation). There is no evidence of exclusion of these named groups. If staff become aware of any clinical exclusions that impact on the delivery of care a Trust Incident form would need to be completed and an appropriate action plan put in place. REFERENCES Green Book Immunisation against infectious disease (2006) Department of Health. Updates are available at The Vaccine Administration Taskforce (2001) UK guidance on best practice in vaccine administration. London: Shire Hall Communications 12/13
13 Royal College of Nursing, (2010) Restrictive physical intervention and therapeutic holding for children and young people Clinical Protocol for Clarification of Parental Responsibility Procedure for Managing an Anaphylactic Emergency Clinical Protocol for Development and Implementation of Patient Group Directions Consent Policy Managing the Quality of Health Records Policy Safe Handling and Administration of Medicines Policy Procedure for the Administration of Medication via the Intramuscular Route or the Subcutaneous Route Basic Life Support Procedures BIBLIOGRAPHY British National Formulary (BNF) always use most current version as changes every six months BNF for Children Health Protection Agency (2005) National Minimum Standards for Immunisation Training Health Protection Agency website Resuscitation Council (2010) Resuscitation Guidelines 13/13
FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING
STANDARD OPERATING PROCEDURE FOR MEDICINE ADMINISTRATION IN COMMUNITY NURSING Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective medicine administration
More informationCLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)
CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration
More informationPROCEDURE FOR TAKING A WOUND SWAB
CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles
More informationWitnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Services
STANDARD OPERATING PROCEDURE Witnessing the Destruction of Stock Controlled Drugs within Wirral Community Trust Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationSTANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION.
STANDARD OPERATING PROCEDURE FOR SAFE AND SECURE MANAGEMENT OF CONTROLLED DRUGS WITHIN PRIMARY CARE DIVISION. Issue History Oct 12 Issue Version Two Purpose of Issue/Description of Change To ensure implementation
More informationSTANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES
STANDARD OPERATING PROCEDURE THE TRANSPORTATION OF PRESCRIBED CONTROLLED DRUGS AND OTHER URGENTLY REQUIRED MEDICATION BY COMMUNITY NURSES Issue History Issue Version Purpose of Issue/Description of Change
More informationSTANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES
STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES First Issued Issue Version One Purpose of Issue/ Description of Change To promote the safe administration
More informationPATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix )
PATIENT GROUP DIRECTION Administration of: By: Practice Nurses Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix ) In: General Practice It is the responsibility of the professional working
More informationGG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Immunisation
More informationPROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS
STANDARD OPERATING PROCEDURE PROCESS FOR INITIATING A SYRINGE DRIVER FOR COMMUNITY NURSE PATIENTS OUT OF HOURS Issue History Issue Version one Purpose of Issue/Description of Change To facilitate patients
More informationCLINICAL PROCEDURE CONSERVATIVE SHARP DEBRIDEMENT FOR COMMUNITY PODIATRISTS
CLINICAL PROCEDURE CONSERVATIVE SHARP DEBRIDEMENT FOR COMMUNITY PODIATRISTS Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 1 To provide Podiatrists with the fundamental
More informationDocument Details. notification of entry onto webpage
Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As
More informationAnaphylactic Reaction Emergency Treatment Reference Number:
This is an official Northern Trust policy and should not be edited in any way Anaphylactic Reaction Emergency Treatment Reference Number: NHSCT/12/551 Target audience: Nursing Staff Groups included are:
More informationUnlicensed Medicines Policy
Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention
More informationPROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN
PROCEDURE FOR CHECKING THE WATER IN BALLOON RETAINED GASTROSTOMY TUBE / LOW PROFILE DEVICES FOR BOTH ADULTS AND CHILDREN First Issued Issue Version Purpose of Issue/Description of Change Planned Review
More informationMedicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017
Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP to nurses, midwives, healthcare workers, agency staff, contract workers and volunteers by registered nurses and
More informationName Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019
PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationPromoting Effective Immunisation Practice
4th Edition 2017 Contents Introduction 3 Who is the programme for? 3 Learning Outcomes 4 Notes for employers 4 Updating 5 Notes for students 6 What are the options for learning? 6 Brief overview of the
More informationNHS Greater Glasgow & Clyde Patient Group Direction (PGD) for Healthcare Professionals Typhoid vaccine (intra muscular administration)
GG&C PGD ref no: 2017/1523 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation in adults
More informationPROTOCOL FOR UNIVERSAL ANTENATAL CONTACT (FOR USE BY HEALTH VISITING TEAMS)
Scope - CP12 PROTOCOL FOR UNIVERSAL ANTENATAL CONTACT (FOR USE BY HEALTH VISITING TEAMS) RATIONALE The Healthy Child Programme Pregnancy and the first five years of life (DH, 2009) states that health professionals,
More informationTHE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS
PGD3717 PATIENT GROUP DIRECTION FOR THESUPPLY OF METRONIDAZOLE 400mg TABLETSFOR THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS (TV) by registered nurses and midwives in Integrated Sexual
More informationIMMUNISATION AND VACCINATION POLICY
IMMUNISATION AND VACCINATION POLICY To be read in conjunction with Medicines Policy and Administration of Injections Policy Version: 3 Ratified by: Senior Managers Operational Group Date ratified: August
More informationCLINICAL PROCEDURE PROCEDURE FOR AN EXPECTED DEATH OF AN ADULT PATIENT FOR COMMUNITY NURSING
CLINICAL PROCEDURE PROCEDURE FOR AN EXPECTED DEATH OF AN ADULT PATIENT FOR COMMUNITY Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To ensure all deceased individuals,
More informationAdministration and checking of medicines by Assistant Practitioners
Document level: Trustwide (TW) Code: MP25 Issue number: 1 Administration and checking of medicines by Assistant Practitioners Lead executive Authors details Type of document Target audience Document purpose
More informationImmunisation Knowledge and Skills Competence Assessment Tool
Immunisation Knowledge and Skills Competence Assessment Tool Second edition CLINICAL PROFESSIONAL RESOURCE IMMUNISATION KNOWLEDGE AND SKILLS COMPETENCE ASSESSMENT TOOL Acknowledgements This publication
More informationCLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS
CLINICAL PROTOCOL FOR THE IDENTIFICATION OF SERVICE USERS RATIONALE All Professionals/healthcare workers are personally accountable for their practice and, in the exercise of their professional accountability,
More informationDublin: Nursing and Midwifery Board of Ireland available at:
Medicine Protocol for the Administration of IPV Boostrix (Diphtheria, Tetanus, Pertussis and Poliomyelitis) vaccine (adsorbed, reduced antigen(s) content) by registered nurses and registered midwives This
More informationPatient Group Drection (PGD) Number : Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 (Gardasil )
Notice to all staff: The Patient Group Directions (PGDs) for the Hertfordshire and South Midlands Area Team may only be used by members of the healthcare professions named on the title page, and only if
More informationAMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy
AMPH-PGN-10 Practice Guidance Note Intramuscular Injection (IMI) V01 Date Issued Planned Review PGN No: Issue 1 Sep 2017 Sep 2020 AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and
More informationPatient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian
NHS Grampian Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian Lead Author: Consultation Group: Approver: Highly
More informationNHS Lothian Patient Group Direction Version: 001
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% TO TREAT MINOR STAPHYLOCOCCAL SKIN INFECTIONS (IMPETIGO) IN PATIENTS AGED OVER 2 YEARS BY PHARMACISTS WORKING WITHIN NHS LOTHIAN COMMUNITY
More informationConsultation Group: See relevant page in the PGD. Review Date: October 2016
Patient Group Direction For The Administration Of Adrenaline (Epinephrine) By Trained Nurses In The Management Of Cardiac Arrest In The Medical High Dependency Unit/Coronary Care Unit (MHDU/CCU) Working
More informationMedicine Protocol for the Administration of HPV vaccine (Gardasil) by registered nurses and registered midwives
Medicine Protocol for the Administration of HPV vaccine (Gardasil) by registered nurses and registered midwives This medicine protocol is a specific written instruction for the administration of Gardasil,
More informationPlease call the Pharmacy Medicines Unit on or for a copy.
Title: PATIENT GROUP DIRECTION FOR THE SUPPLY OF FLUCONAZOLE 150MG UNDER THE MINOR AILMENT SERVICE Identifier: Across NHS Boards Organisation Wide Directorate Clinical Service Sub Department Area This
More informationPGD5417. Clinical Performance Director of Nursing Allison Bussey
PGD5417 Patient Group Direction Administration of Adrenaline (Epinephrine) 1:1000 (1mg/ml) Injection By Registered Nurses and Midwives employed by South Staffordshire & Shropshire Healthcare Foundation
More informationJob Title Name Signature Date
Supply of Fluconazole 150mg capsule by Community Pharmacists working in Forth Valley Pharmacies under NHS Minor Ailment Service. Protocol Number 125 Version 5 Date protocol prepared: November 2014 Date
More informationThis guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.
CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More informationPromoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated Click Here
Promoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated 2011 Click Here Promoting Effective Immunisation Practice Published Summer 2011 NHS Education for Scotland
More informationPromoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated Click Here
Promoting Effective Immunisation Practice Guide for Students, Mentors and Their Employers Updated 2014 Click Here Promoting Effective Immunisation Practice Published Summer 2014 NHS Education for Scotland
More informationGG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2011/841 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria:
More informationClinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.
Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and
More informationNBCP PO C Administration of injections
POLICY CATEGORY: POLICY FOCUS: POLICY NAME: Administration of injections policy (EN) LAST UPDATED: February 2014 MOTION NUMBER: C-14-02-08 OTHER: GM-PP-I-03 (Supplement to administration of injections
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:
More informationHealth & Social Services
The States of Jersey Department for Health & Social Services AGREED PROCESS FOR COMMUNITY INTRAVENOUS THERAPY Date approved DOCUMENT PROFILE Document Registration Document Purpose Short Title Author Publication
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationAdministration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure
Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Quality and Standards Group Date
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING
More informationSAFE HANDLING OF PRESCRIPTION FORMS FOR PRIMARY AND UNPLANNED CARE DIVISIONS
STANDARD OPERATING PROCEDURE SAFE HANDLING OF PRESCRIPTION FORMS FOR PRIMARY AND UNPLANNED CARE DIVISIONS Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To ensure
More informationCLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES
CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES RATIONALE Access to Community Podiatry services and treatment intervals for Diabetic patients, will generally be determined by the
More informationPROCEDURE FOR CONSERVATIVE DEBRIDEMENT
CLINICAL PROCEDURE PROCEDURE FOR CONSERVATIVE DEBRIDEMENT Issue History Issue Version One Purpose of Issue/Description of Change To promote safe and effective sharp debridement by Tissue Viability Specialists
More informationPatient Group Direction For the supply of Fusidic Acid 2% Cream
Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may
More informationDISTRICT NURSING and INTERMEDIATE CARE
CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2 Date protocol prepared: October 2017 Date protocol due for review: October 2019 Expiry date: October
More informationGG: Immunization Specialty
GG: Immunization Specialty College of Licensed Practical Nurses of Alberta, Competency Profile for LPNs, 3rd Ed. 255 Competency: GG-1 Self-Regulation and Accountability GG-1-1 GG-1-2 Demonstrate knowledge
More informationMENINGOCOCCAL SEROGROUP B IMMUNISATION FOR INFANTS. Service Specification
MENINGOCOCCAL SEROGROUP B IMMUNISATION FOR INFANTS Service Specification National Enhanced Service Specification for Meningococcal Serogroup B (MenB) Vaccination Programme. Introduction 1. This programme
More informationAppendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD)
Appendix 3 Cardiac Catheter Lab at Musgrove Park Hospital PATIENT GROUP DIRECTION (PGD) PGD for the supply/administration of: Lidocaine 1% and Adrenaline 1:200,000 Master document reference number: This
More informationPatient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019
Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history
More informationIntravenous Medication Administration via a Central Venous Line
Standard Operating Procedure 11 (SOP 11) Intravenous Medication Administration via a Central Venous Line Why we have a procedure? This procedure is to assist/ inform healthcare professionals on how to
More informationNHS GREATER GLASGOW AND CLYDE POLICIES RELATING TO THE MANAGEMENT OF MEDICINES SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION)
SECTION 9.1: UNLICENSED MEDICINES POLICY (ACUTE DIVISION) CONTENTS POLICY SUMMARY... 2 1. SCOPE... 4 2. AIM... 4 3. BACKGROUND... 4 4. POLICY STATEMENTS... 5 4.1. GENERAL STATEMENTS... 5 4.2 UNLICENSED
More informationInfection Control Safety Guidance Document
Infection Control Safety Guidance Document Lead Directorate and Service: Corporate Resources - Human Resources, Safety Services Effective Date: June 2014 Contact Officer/Number Garry Smith / 01482 391110
More informationName Job Title Signed Date
PGD3517 PATIENT GROUP DIRECTION FOR THE SUPPLY OF AZITHROMYCIN TABS/CAPS 250mg or TABS 500mg OR SUSPENSION 600mg/15mL FOR UNCOMPLICATED GENITAL CHLAMYDIA TRACHOMATIS, UNCOMPLICATED NEISSERIA GONORRHOEA
More informationRisk Assessment Form HS 9 (1)
s Full Name: Date of Birth: NHS Number 1. The fully implanted port system Sitimplant is not regularly used in the community and nursing staff may be unfamiliar with the recommended care of this system
More informationConsultation Group: See relevant page in the PGD. Review Date: May Expiry Date: May 2020
NHS...... Grampian Patient Group Direction For The Administration Of Lidocaine Hydrochloride 1% Injection As Infiltration Anaesthesia For Insertion/Removal Of Tunnelled Central Venous Catheters By Nurses/Radiographers
More informationSupply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.
Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over. November 2017 Review Nov 2019 Signatures of those developing the Patient Group
More informationPatient Group Direction For The Administration Of Japanese Encephalitis Vaccine (IXIARO ) By Nurses And Pharmacists Working Within NHS Grampian
Patient Group Direction For The Administration Of Japanese Encephalitis Vaccine (IXIARO ) By Nurses And Pharmacists Working Within NHS Grampian Lead Author: Medicines Management Specialist Nurse Consultation
More informationPROCEDURES FOR EYE CARE
m PROCEDURES FOR EYE CARE 1. CLEANSING OF THE EYE 2. INSTILLATION OF EYE DROPS/OINTMENTS 3. CARE OF AN EYE PROSTHESIS 4. EYE IRRIGATION FOR ADULTS AND CHILDREN (WALK-IN CENTRES ONLY) Issue History Issue
More informationGG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation in adults
More informationGROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS. Version 4 December 2017
GROUP PROTOCOL FOR THE MANAGEMENT OF SIMPLE MOUTH ULCERS Version 4 December 2017 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES December 2020 EXECUTIVE SPONSOR Chief Nurse
More informationUncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES
Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company
More informationPATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG CAPSULES / TABLETS FOR THE FIRST- LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION
This Patient Group Direction () must only be used by registered pharmacists who have been named and authorised by their organisation to practice under it. The most recent and in date final signed version
More informationDerby Hospitals NHS Foundation Trust. Drug Assessment
Drug Assessment for Preparation and Administration of Oral, Enteral, Ophthalmic, Topical, PR, PV, Inhaled, Subcutaneous and Intramuscular Medicines to Patients (N.B. The preparation and administration
More informationGG: Immunization Specialty
GG: Immunization Specialty Alberta Licensed Practical Nurses Competency Profile 315 Competency: GG-1 Authorization and Certification in Immunization GG-1-1 GG-1-2 Demonstrate understanding of restricted
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 Date protocol prepared: December 2015 Date protocol due for review: December 2017 This patient group direction
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:
More informationSAFE HANDLING OF PRESCRIPTION FORMS FOR DOCTORS AND DENTISTS
STANDARD OPERATING PROCEDURE SAFE HANDLING OF PRESCRIPTION FORMS FOR DOCTORS AND DENTISTS Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date One To ensure robust systems
More informationRegister No: Status: Public
ADMINISTRATION OF VITAMIN K FOR NEONATES CLINICAL GUIDELINES Register No: 08095 Status: Public Developed in response to: Contributes to CQC Outcome 11,12 Intrapartum NICE Guidelines CNST Requirement Consulted
More informationAdministration of Medicines by Powys Community Nurses and Allied Health Care Professionals to Residents in Glan Irfon
Administration of Medicines by Powys Community Nurses and Allied Health Care Professionals to Residents Document Code PTHB / CDP 013 Date Version Number Review Date May 2014 1 May 2017 Document Owner Approved
More informationCommunity Intravenous Therapy Referral Standards
pecialist harmacy ervice Medicines Use and afety Community Intravenous Therapy Referral tandards Background A multi-centred audit of prescribing and administration of community IV therapy across East and
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Patients who require an antihistamine
More informationLevel 2 Award in Healthcare and Social Care Support Skills
Level 2 Award in Healthcare and Social Care Support Skills Qualification Specification ProQual 2015 Contents Page Introduction 3 The Qualifications and Credit Framework (QCF) 3 Qualification profile 4
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationUnlicensed Medicines Policy Document
Unlicensed Medicines Policy Document Effective: February 2002 (Intranet 2006) Review date: February 2007 A. Introduction In order to ensure that medicines are safe and effective the manufacture and sale
More informationAdult Protocol Intermittent Catheterisation
Adult Protocol Intermittent Catheterisation Page 1 of 8 Policy reference: Continence Introduction Adult Protocol Intermittent Catheterisation This protocol covers management of incomplete bladder emptying
More informationMedication Management Policy and Procedures
POLICY STATEMENT This policy establishes guidelines for ensuring safe and correct management of client medications in accordance with legislative and regulatory requirements and professional practice competency
More informationMandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL
Mandatory Competency Assessment for Medicines Management (Not Injectable Medicines) for Registered Practitioners IN HOSPITAL Document Author Written by: Lead Pharmacist/Lead Technician Medicines Use and
More informationCLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical
More informationU: Medication Administration
U: Medication Administration Alberta Licensed Practical Nurses Competency Profile 199 Competency: U-1 Pharmacology and Principles of Administration of Medications U-1-1 U-1-2 U-1-3 U-1-4 Demonstrate knowledge
More informationIt is each Integrated CMHT Manager s responsibility to ensure adherence to this procedure.
Date of Next Review: 7 Apr 2019 Previous Trust/LHB Reference Number: N/A Depot Medication Procedure and Protocol for the Administration of Depot Medication in Community Mental Health Teams Reference Number:
More informationPARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationJOB DESCRIPTION. 2. To participate in the delivery of medicines administration depending on local need and priorities.
JOB DESCRIPTION JOB TITLE: Clinical Pharmacy Technician PAY BAND: 5 DEPARTMENT/DIVISION: BASED AT: REPORTS TO: PHARMACY/A5 University Hospitals Birmingham Pharmacy Support Manager PROFESSIONALLY RESPONSIBLE
More informationTAKING VENOUS BLOOD SAMPLES FROM HEALTHY ADULT VOLUNTEERS
TAKING VENOUS BLOOD SAMPLES FROM HEALTHY ADULT VOLUNTEERS 1. SCOPE A number of studies performed in the University involve taking samples of venous blood from participants. A wide variety of tests may
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Decontamination of Healthcare Equipment following Patient Use and Prior to Service or Repair
The Newcastle upon Tyne Hospitals NHS Foundation Trust Decontamination of Healthcare Equipment following Patient Use and Prior to Service or Repair Version No.: 5.0 Effective From: 27 December 2017 Expiry
More informationNon-Medical Prescribing Passport. Reflective Log And Information
Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and
More informationADMINISTRATION OF APOMORPHINE VIA THE APO-GO PUMP
STANDARD OPERATING PROCEDURE ADMINISTRATION OF APOMORPHINE VIA THE APO-GO PUMP First Issued Issue Version One Purpose of Issue/Description of Change To promote safe and effective administration of subcutaneous
More informationMEDICAL CONDITIONS AND MEDICATION POLICY
Round Oak School, Support Service & Sports College MEDICAL CONDITIONS AND MEDICATION POLICY Reviewed: June 2013 Next Review: Summer 2016 (unless it is necessary to be revised sooner) Reviewed: Autumn 2016
More information